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ABSTRACT
Colicin E5—a tRNase toxin—specifically cleaves
QUN (Q: queuosine) anticodons of the Escherichia
coli tRNAs for Tyr, His, Asn and Asp. Here, we report
the crystal structure of the C-terminal ribonuclease
domain (CRD) of E5 complexed with a substrate
analog, namely, dGpdUp, at a resolution of 1.9 A ˚. This
structure is the first to reveal the substrate recogni-
tion mechanism of sequence-specific ribonucleases.
E5-CRD realized the strict recognition for both
the guanine and uracil bases of dGpdUp forming
Watson–Crick-type hydrogen bonds and ring stack-
ing interactions, thus mimicking the codons of
mRNAs to bind to tRNA anticodons. The docking
model of E5-CRD with tRNA also suggests its sub-
strate preference for tRNA over ssRNA. In addition,
the structure of E5-CRD/dGpdUp along with the
mutational analysis suggests that Arg33 may play
an important role in the catalytic activity, and Lys25/
Lys60 may also be involved without His in E5-CRD.
Finally, the comparison of the structures of E5-CRD/
dGpdUp and E5-CRD/ImmE5 (an inhibitor protein)
complexes suggests that the binding mode of E5-
CRD and ImmE5 mimics that of mRNA and tRNA; this
may represent the evolutionary pathway of these
proteins from the RNA–RNA interaction through
the RNA–protein interaction of tRNA/E5-CRD.
INTRODUCTION
Colicins, which are produced by bacteria carrying the corre-
sponding Col plasmids, kill sensitive Escherichia coli cells
through activities involving the ion channels in the inner
membranes, DNases or RNases (1,2). The DNase-type
colicins nonspeciﬁcally degrade the genomic DNAs of the
sensitive cells (3–5), whereas those of the RNase type cleave
16S rRNA at the 49th phosphodiester bond from the 30 end
(6–8). These colicins contain three domains—a membrane-
translocating domain, a receptor-binding domain, and a cat-
alytic domain—in their primary sequences. Colicinogenic
cells also produce inhibitor proteins (Imm), the genes for
which are located downstream of the col genes in the colicin
operons that are under the control of the SOS-dependent pro-
moters. Imms bind speciﬁcally to cognate colicins in order to
protect their host cells.
In addition to the known RNase-type colicins, colicin E5
that has been recently characterized as a tRNase has a unique
target for its toxicity. It speciﬁcally cleaves the anticodons
of E.coli tRNAs for Tyr, His, Asn and Asp. These tRNAs
decode NAY (N: any nucleotide, A: adenosine and Y: a
pyrimidine nucleotide) codons by means of QUN anticodons,
where queuosine (Q) is a 7-deazaguanosine with a cyclopen-
tenediol side chain (9). Initially, colicin E5 was observed to
cleave only the QU sequence of these tRNAs between posi-
tions 34 and 35, leaving a 20,30-cyclic phosphate on Q and
a5 0-OH on U. In tRNA-guanine transglycosylase-deﬁcient
strains the inherent G is not replaced with a precursor base
of Q; this gives rise to tRNAs with GUN anticodons. These
strains were demonstrated to be sensitive to colicin E5; the
tRNAs were still subjected to cleavage (10). It is assumed
that colicin E5 consists of 556 amino acids (11). The ribonu-
clease activity of E5 resides solely within its C-terminal
ribonuclease domain (E5-CRD; 115 amino acids), and this
domain is responsible for its substrate speciﬁcity. Further-
more, based on the results obtained from our assay using
synthetic minihelices or linear oligoribonucleotides, E5-CRD
can be referred to as an RNA restriction enzyme that
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sequences (12).
In addition to colicin E5, colicin D (13), PrrC (14) and
zymocin (15) are also known to be tRNases. However,
these enzymes are nonhomologous with each other and
target tRNAs and cleavage sites that are different from
those targeted by colicin E5. Colicin D, which is produced
by E.coli harboring a ColD plasmid, cleaves only four
isoacceptors of tRNA
Arg between positions 38 and 39 at the
30 junction of the anticodon stem and loop. PrrC is induced
in some E.coli isolates by T4 phage infection, and it
only cleaves tRNA
Lys between positions 33 and 34 at the
50 side of the anticodon. Zymocin, which is produced by
Kluyveromyces lactis, was recently reported to cleave some
yeast tRNAs at the 30 side of the modiﬁed nucleotide U in the
anticodons of 5-methoxycarbonylmethyl-2-thiouridine uridine
cytosine (mcm
5s
2UUC), mcm
5s
2UUU and mcm
5s
2UUG.
Among these tRNases, the crystal structure of the C-terminal
catalytic domain of colicin D (D-CRD) has been solved
(16,17); the structure revealed a curved row of basic residues
on the molecular surface that could confer the tRNA
recognition speciﬁcity.
ImmE5—a speciﬁc inhibitor protein of colicin E5—is
expressed in host cells and binds to E5-CRD to prevent cell
death. In addition to the nuclease-type colicin family, this
type of proteinaceous toxin–antitoxin system (comprising
addiction molecules), including MazE/F (18) and RelB/E
(19) whose targets are considered to be the ACA sequences
in mRNAs and stop codons of mRNAs in the ribosomal A
site, respectively, has also been well studied. The study of
these molecules reveals the survival mechanism in bacteria;
additionally, they serve as very good examples of protein–
protein interactions. Furthermore, from the structural
viewpoint, it is of special interest to determine whether
ribonuclease inhibitors, i.e. inhibitors of toxins that target
DNA or RNA, bind to the corresponding enzymes by
mimicking the substrate RNAs/DNAs.
Further, although E5-CRD exhibits ribonuclease activity,
it lacks His that usually serves as a catalytic residue in
all known ribonucleases. Thus, E5-CRD must have an alter-
native mechanism that is responsible for its ribonuclease
activity.
Since E5-CRD shows no homology with any other pro-
teins, we performed the structural analysis of E5-CRD in
order to explore the novel features of colicin E5. Recently,
Huang’s group has reported the structures of E5-CRD (20)
and E5-CRD complexed with ImmE5 (21) at a resolution
of 1.5 and 1.15 s, respectively; they also proposed a putative
model of the interaction between E5-CRD and tRNA.
However, the precise structure of the active site in the pocket
with catalytic residues remains unknown. Here, we report the
crystal structures of E5-CRD complexed with its substrate
analog and E5-CRD complexed with ImmE5. These struc-
tures clearly demonstrate the mechanism by which speciﬁc
substrate recognition is achieved and reveal the residues
that could play important roles for the catalytic activity in
the absence of His. Based on these structures, we propose
the double mimicry model to demonstrate the mechanism
by which the protein–protein interaction replaces the RNA–
RNA interaction.
MATERIALS AND METHODS
Plasmids
The pTO502 E5-CRD/ImmE5 expression plasmid was used
for the crystallization; this plasmid was a derivative of
pTO501, which has been described previously (10). The
pTO501 plasmid contained a single mutation of I62M that
was attributed to a PCR-cloning artifact in ImmE5; thus,
this plasmid produces the wild-type ImmE5.
The pKF601 expression plasmid was used for the cell-
killing assay. This plasmid contained an operon coding for
colicin E5 and ImmE5 that was under the control of the
colicin promoter. The pKF601 plasmid was constructed
using the pTO502 plasmid, in which the colE5-immE5 frag-
ment from pColE5-099 was replaced with the E5-CRD/
immE5 fragment. The K25Q, R33Q, K60Q and K25Q/
K60Q mutants of colicin E5 were constructed based on the
pKF601 plasmid using the Quickchange mutagenesis kit
(Stratagene, La Jolla, CA).
Protein expression and purification
The protein expressions from both plasmids pTO502 and
pKF601 including its derivatives were induced by the addi-
tion of 0.2 mg/l mitomycin C, which activates the colicin
promoters.
For crystallization, the E5-CRD/ImmE5 complex was
puriﬁed from E.coli K12 RR1 [pTO502] using a Phenyl-
Toyopearl 650 M column (Tosoh Co., Tokyo, Japan) with a
decreasing gradient starting at 1 M ammonium sulfate in
20 mM potassium phosphate buffer (pH 7.0); this was
followed by puriﬁcation using a DEAE-Toyopearl 650S
column (Tosoh Co.) with a KCl gradient elution in 20 mM
Tris–HCl (pH 8.5). In order to obtain the E5-CRD protein,
the E5-CRD/ImmE5 complex was dissociated using 6 M
urea in 20 mM Tris–HCl (pH 8.5), and E5-CRD was
separated on a MonoQ column and then renatured by dialysis
in 20 mM Tris–HCl (pH 8.5).
For the cell-killing assay, the E.coli K12 RR1 strain was
also used as a host for the expression of the wild-type
(pKF601) or the mutant (pKF601 derivatives) colicin E5/
ImmE5 complexes. The puriﬁcation of the complex proteins
was performed using a DEAE-Toyopearl 650S column in
20 mM Tris–HCl (pH 8.0) with a 0–0.5 M KCl gradient,
followed by puriﬁcation using a MonoS column in 20 mM
potassium phosphate (pH 6.0) with a 0–0.5 M KCl gradient.
Crystallization and data collection
An I222 crystal of the E5-CRD/ImmE5 complex was
obtained by the hanging-drop vapor diffusion method using
2 M ammonium sulfate and 0.1 M Tris–HCl (pH 8.0) at
20 C. A P212121 crystal of the E5-CRD/dGpdUp complex
was also obtained under the same conditions as those for
the E5-CRD/ImmE5 complex. For the E5-CRD/dGpdUp
complex, synthesized and HPLC-puriﬁed dGpdUp was
mixed with the E5-CRD protein in a 2:1 molar ratio. The
X-ray data of the E5-CRD/ImmE5 crystal were collected
using a DIP2030 (MacScience Inc., Yokohama, Japan) with
an image plate area detector system. The E5-CRD/dGpdUp
crystals were ﬂash-frozen in a 100 K nitrogen stream with
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voir solution. The data were collected on beamline BL41XU
at SPring-8. Both the data were processed using the DENZO
and SCALEPACK programs (22).
Structure determinations and refinements
The E5-CRD/ImmE5 complex structure was solved by the
multiple isomorphous replacement (MIR) method, and it
was reﬁned at a 1.9 s resolution to an R-factor of 17.9%
(Rfree ¼ 19.8%). MIR phasing and reﬁnement of the heavy
atom positions were carried out using the program
MLPHARE, and density modiﬁcation was performed using
the program DM. Iterative rounds of reﬁnement and
rebuilding of the native model were performed by using the
programs CNS (23) and QUANTA (Accelrys Inc., San
Diego, CA), respectively. The structure of E5-CRD com-
plexed with dGpdUp was determined by the molecular
replacement method using the program AMoRe. The E5-
CRD coordinates obtained by MIR were used as a target.
The programs MLPHARE, DM and AMoRe are included
in the CCP4 suite (24). The structure was reﬁned at a 1.9 s
resolution to an R-factor of 19.7% (Rfree ¼ 21.7%). Figures 1,
3, 5, 6 and 7 were created using PyMOL (25), and Figure 2
was created using Molscript (26). The atomic coordinates
and structure factors of the E5-CRD/ImmE5 and E5-CRD/
dGpdUp complexes have been deposited in the PDB under
the accession codes 2DFX and 2DJH, respectively.
Cell-killing assays
Cell-killing assays were performed by a spot test. Wild-type,
K25Q, R33Q, K60Q and K25Q/K60Q colicin E5s were
serially diluted from a starting concentration of 65 mg/ml
by a factor of two using L-broth medium, and 3 ml of each
dilution was applied onto a soft agar lawn of a sensitive
indicator strain (E.coli K12 RR1). After overnight incubation
at 37 C, the growth inhibition zones were compared.
RESULTS
Crystallizations and structure determinations
The crystals of the E5-CRD/ImmE5 complex grew to a
typical size of 0.2 · 0.2 · 0.4 mm within a week. The data
were collected in the absence of a cryocooling condition;
this resulted in a very low mosaicity of 0.15 as calculated
by the software SCALEPACK (22). In order to solve the
phase problem, the platinum and mercury derivative crystals
were used for the MIR methods.
The deoxy derivative dGpdUp was used as a substrate
analog for the crystallization of E5-CRD because E5-CRD
very efﬁciently cleaves between the G and U of the target
tRNAs, and the diribonucleotide GpUp was also speciﬁcally
cleaved by E5-CRD in vitro (12). E5-CRD and dGpdUp were
co-crystallized to obtain the complex; the crystals appeared in
a few days and grew to a maximum size of 0.3 · 0.3 ·
0.7 mm within a week. The diffraction data were collected
at 100 K under a liquid nitrogen stream. The molecular
replacement method was applied to solve the structure by
using the coordinates of E5-CRD in the ImmE5 complex as
the search model. The data were collected at 1.8 s and
reﬁned at 1.9 s because the reﬁnement at 1.8 s did not
improve the statistics. The Ramachandran plot analysis of
the reﬁned structure showed that 92% of the residues were
in the most favored regions, and the remaining residues
were in additional allowed regions.
The data collection and the reﬁnement statistics for both
crystals are summarized in Table 1.
Table 1. Data collection, phase determination and refinement statistics of E5-CRD/dGpdUp and E5-CRD/ImmE5
E5-CRD/dGpdUp E5-CRD/ImmE5
Native Native K2PtCl4 Mersalyl acid
Data collection
Space group P212121 I222
Cell dimensions
a, b, c (s) a ¼ 29.7, b ¼ 49.4, c ¼ 63.9 a ¼ 63.5, b ¼ 74.4, c ¼ 111.2
Resolution (s) 1.8 (1.86–1.80) 1.86 (1.93–1.86) 2.4 (2.49–2.40) 1.86 (1.93–1.86)
Rmerge
a 0.046 (0.131) 0.040 (0.197) 0.059 (0.145) 0.076 (0.405)
I/sI 20.8 (8.8) 11.1 (5.7) 12.3 (7.0) 7.4 (2.9)
Completeness (%) 99.2 (100.0) 92.7 (73.0) 93.5 (62.8) 97.9 (82.0)
Total reflections 116 803 124 539 77 483 159 223
Unique reflections 8694 20 556 9087 21 662
Number of sites 31
Rcullis
b 0.51 0.68
Phasing power
c 1.4 0.9
Refinement
Resolution (s) 26.5–1.9 19.1–1.9
Number of reflections 7399 19 713
Rwork/Rfree
d 0.197/0.217 0.179/0.198
R.m.s. deviations
Bond lengths (s) 0.005 0.005
Bond angles ( ) 1.3 1.3
aRmerge ¼ ShSi |Ii(h)  < I(h) > |/ShSiIi(h), where Ii(h) is the ith measurement.
bRcullis ¼ S[|FH|   (|FPH|   |FP|)]/S(|FPH|   |FP|), where |FH| represents the calculated heavy atom structure factor.
cPhasing power ¼ frms/Erms, where frms ¼ [(Sf
2
H)/n]
1/2 and Erms ¼ [S(FPH   |FP + fH|)
2/n]
1/2.
dR ¼ S|FO   FC|/SFO for all reflections and Rfree ¼ S|FO   FC|/SFO, calculated with the 5% of the data excluded from refinement.
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In the crystal structure of E5-CRD complexed with dGpdUp,
the dinucleotide is tightly trapped in the pocket of E5-CRD.
As shown in Figure 1, the pocket is formed by a long partially
coiled loop on the left, the parallel a-helix at the back, and
the C-terminal loop on the right. The nucleotide conforma-
tions are syn and anti for dG and dU, respectively. Although
the anti conformation is known to be predominant for dG
in solution, the syn conformation for dG in our structure is
stabilized by interactions with E5-CRD, as described below.
The sugar puckers of the deoxyribose rings are C40-exo and
C20-endo for dG and dU, respectively.
The superposition of three E5-CRD structures—one
complexed with dGpdUp, another with ImmE5, and the apo
form (PDB code 2A8K)—showed that they ﬁt well in the
central region of the b-sheet with the a-helix being parallel
to the b-sheet (parallel a-helix); however, they exhibit slight
differences at both ends of the b-sheet and the C-terminal
region. The structure with the analog had the most closed
conformation. This observation suggests the ﬂexibility of
E5-CRD to bind both tRNAs and ImmE5 (Figure 2).
The most interesting feature is the speciﬁc interaction
between the dinucleotide and the protein surface. The gua-
nine base is stacked with the indole ring of Trp102; these
two double rings face each other, and the distance between
them is almost the same as that of B-DNA. In addition, the
guanine base forms three hydrogen bonds—O6 of dG with
amide N of Val103, N1 of dG with carbonyl O of Val103,
and N2 of dG with carbonyl O of Val103. With regard to
the dU moiety of the substrate analog, the uracil base forms
three hydrogen bonds—O4 of dU with hydroxyl O of Ser52,
N3 of dU with carbonyl O of Phe53 and O2 of dU with
amide N of Lys55. The uracil base ring also undergoes
a stacking interaction with a pseudo ring formed by the
carboxyl group of Asp105 and the guanidino group of
Arg107 (Figure 3A). The distance between the uracil base
and the pseudo ring is the same as that between the guanine
base and the indole ring of Trp102 mentioned above.
While the base rings are restrained by hydrogen bonds and
ring interactions, backbone phosphates are also retained by
several hydrogen bonds. The phosphate between dG and dU
forms hydrogen bonds with NH2 of Arg33, NE2 of Gln29
and NZ of Lys25, whereas the 30-terminal phosphates form
hydrogen bonds with hydroxyl O and amide N of Ser57
and NZ of Lys60 (Figure 3B).
The inspection of the structure surrounding the substrate
analog revealed a positively charged cluster that was
composed of two Lys and one Arg residues (Figure 3B).
These residues are positioned in proximity to the phosphodi-
ester bond between dG and dU, and no other charged
side chains were present close to this bond. As shown in
Figure 3B, Arg33 extends its side chain to the phosphate
group from the guanosine side, while Lys25 and Lys60 do
so from the uridine side. The distances between NH1 of
Arg33 and O1P and that between NH1 of Arg33 and the
expected position of 20-O of guanine are 2.8 and 3.5 s,
respectively. In addition, the distances between NZ of
Lys25 and 50-O and that between NZ of Lys60 and 50-O of
uridine are 4 and 3.5 s, respectively.
Cell-killing assay
Based on the structure of the E5-CRD/dGpdUp complex,
three basic residues were implicated to be important for
the tRNase activity. Hence, we introduced four types of
mutations—R33Q, K25Q, K60Q and K25Q/K60Q—in the
C-terminal domain of colicin E5 and analyzed their killing
activities (Figure 4). Serial dilution of puriﬁed colicin E5s
clearly showed that mutations R33Q and K25Q/K60Q
abolished the killing activity of the protein against sensitive
cells; on the other hand, K25Q or K60Q reduced the killing
activity.
DISCUSSION
Sequence-specific recognition mechanism of E5-CRD
Among the colicin family proteins, the crystal structure of
RNase-type colicin E3 has been reported (27,28). Colicins
E3 and E5 are homologous at the receptor-binding and
membrane-translocating domains. On the other hand, the
Figure 1. Stereoview of the E5-CRD/dGpdUp complex structure. E5-CRD is
represented as a ribbon model and dGpdUp, as a ball-and-stick model. The
Fo–Fc omit map of dGpdUp (s ¼ 1.0) is also presented.
Figure 2. The superposition of three E5-CRD structures. The E5-CRD
structure complexed with dGpdUp, another complex with ImmE5, and the
apo form (PDB code 2A8K) are shown in pink, yellow and purple,
respectively. The dGpdUp structure is also shown as a ball-and-stick model.
Nucleic Acids Research, 2006, Vol. 34, No. 21 6077Figure 3. The binding mode of dGpdUp to E5-CRD. (A) The Watson–Crick-type interaction between dGpdUp and E5-CRD. The cyan- and purple-colored
residues contribute to the interactions with ring–ring interactions and the hydrogen bonds of nucleotide bases, respectively. (B) The yellow-colored residues
contribute to the interactions with the phosphates of dGpdUp. (C) A schematic representation of the Watson–Crick-type hydrogen bonds between E5-CRD and
dGpdUp, which mimic the mRNA–tRNA interaction. The yellow- and green-colored column pairs at the left and at the right show E5-CRD/tRNA(dGpdUp) and
mRNA/tRNA interactions, respectively.
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ogy, reﬂecting completely different targets. Colicin E5 is a
tRNase that speciﬁcally targets the GU and QU sequences
of the anticodons speciﬁcally. In order to understand this spe-
ciﬁc recognition mechanism, we solved the crystal structure
of the C-terminal tRNase domain of colicin E5 complexed
with its substrate analog, dGpdUp. The tight binding of
dGpdUp to E5-CRD was achieved by ring–ring-interactions
and the maximum possible hydrogen bonds, suggesting the
mimicry of Watson–Crick-type interactions in both dG and
dU (Figure 3A and C). If the dG base were to be substituted
by dA, none of these hydrogen bonds would be possible. In
contrast, if the same dG base was to be substituted by a
Q base, all these hydrogen bonds would be retained, while
the modiﬁcation extending from the N7 position would easily
extend into the solvent. The above modeling consideration is
consistent with the experimental observation that the tRNAs
with Q as well as the corresponding molecules without Q are
cleaved by E5-CRD.
If the dU base were to be substituted by dC, only one
hydrogen bond would be retained. Thus, the nucleotide
sequence G (or Q)-U appears to be favored by E5-CRD
through the formation of maximum possible hydrogen
bonds and aromatic ring (or pseudo ring) stacking
interactions. All the hydrogen bonds use the backbone
amide N or carbonyl O of E5-CRD, except hydroxyl O
of Ser52.
In addition to the interactions of the bases by the hydrogen
bonds and ring interactions, backbone phosphates are also
retained by several hydrogen bonds. Thus, this observation
also suggests that E5-CRD has less ﬂexibility for substrate
recognition; this results in binding to only the speciﬁc target.
These ﬁndings explain that the speciﬁc cleavage of
the Q(G)UN anticodon sequence by E5-CRD is based on
the GU-speciﬁc base recognition by E5-CRD. In addition,
this speciﬁc recognition between the protein and the RNA
is realized in a manner similar to the Watson–Crick-type
interaction used in an RNA double strand.
There are several examples of RNAs being processed in a
site-speciﬁc manner. MazF and ChpBK cleave free RNAs at
the ACA and ACY (Y: U, A or G) sequences, respectively
(29,30). Both proteins are E.coli chromosomal toxins and
inhibit translation by cleaving mRNA. The crystal structure
of MazF has been recently reported (31); however, no
structural information on its substrate binding is available.
Although there should be a large number of GU sequences
in cellular RNAs, E5 preferentially acts on tRNA anticodons
in vivo (10). When we docked E5-CRD and a tRNA molecule
(tRNA
Asp, PDB code 1ASY) manually by superimposing
dGpdUp and GU of the tRNA, E5-CRD made contact only
with the anticodon arm of tRNA (Figure 5). Interestingly,
the parallel helix of E5-CRD ﬁts in the helix of the anticodon
arm. This may explain the substrate speciﬁcity of tRNA,
where E5-CRD tightly binds to tRNA thereby allowing the
capture of G–U bases at the bottom of the binding pocket.
Therefore, E5-CRD may prefer GU sequences embedded in
speciﬁc secondary structures such as anticodon loops, and
in fact, the enzyme kinetic study also demonstrated this GU
preference by E5-CRD (12).
Which amino acids serve as the catalytic residues?
If E5-CRD is a true ribonuclease that lacks His, which
residues serve as the catalysts? Based on the crystal structure
of the E5-CRD/dGpdUp complex, only Lys25, Lys60 and
Arg33 were observed as charged residues with the proximity
of the phosphates in the substrate (Figure 3B). With reference
Figure 4. Cell-killing assay. Purified wild-type colicin E5, K25Q, R33Q,
K60Q or K25Q/K60Q was applied on a soft agar lawn of sensitive E.coli
cells. The proteins were serially diluted by a factor of two starting at a
concentration of 65 mg/ml.
Figure 5. Docking model of E5-CRD and tRNA. The tRNA
Asp from 1asy.pdb
was manually docked to E5-CRD from the dGpdUp complex structure. The
tRNA was placed at the position where G–U in its anticodon, which is shown
as a ball-and-stick model, superposed onto dGpdUp of the E5-CRD complex.
The right figure is a side view of the left figure.
Nucleic Acids Research, 2006, Vol. 34, No. 21 6079to the well-studied case of pancreatic RNase A in which
His12 is a general base located close to 20-OH and His119
is a general acid located close to 50-O in the 20,30-cyclizing
step (32), Arg33 may position itself corresponding to that
of His12, and Lys25 or Lys60 may position itself correspond-
ing to that of His119. The mutation analysis revealed that
both R33Q and K25Q/K60Q mutants lost their killing
activity, and either of the K25Q or the K60Q mutant exhib-
ited a decreased activity. Thus, this result suggests that
these three basic residues are important for the catalytic
activity. Interestingly, E5-CRD preferred a very high pH to
cleave a dinucleotide substrate (12). The normally accepted
pKa values of the Arg and Lys side chains might explain
this unusual pH preference. In addition, the carbonyl group
of Ile94 is close to the guanidino group of Arg33, thereby
forming a hydrogen bond; this possibly increases the basicity
of the protonated guanidino group of Arg33. However, we
could not thoroughly measure the activity at higher pH values
due to RNA instability. On the other hand, in E.coli cells, in
which it is difﬁcult to achieve high pH values under physio-
logical conditions, both Arg and Lys are assumed to be pro-
tonated. Thus, it is unlikely for these basic residues to
function as general acid–base catalysts.
Lin et al. have reported the crystal structure of the apo
form of E5-CRD; they showed that Asp54, Arg56, Lys59,
Asp105 and Arg107 (corresponding to their residue numbers
Asp46, Arg48, Lys51, Asp97 and Asp99, respectively)
affected its ribonuclease activity due to mutations (20).
Further, among these residues, Asp54 and Arg56 were
suggested to be putative catalytic residues. Based on the
structure of our complex, however, the Ca atoms of Asp54
and Arg56 were located approximately 14 and 11 s, respec-
tively, apart from the 20-C atom of the deoxyguanosine of
dGpdUp; in addition, the residues were blocked by uridine
thereby preventing their contact with the 20-C atom and the
phosphate group between dG and dU. Furthermore, instead
of playing a role in substrate binding, Asp54 and Arg56
formed a salt bridge, enabling the complex structure to
maintain its conformation. In addition, Asp105–Arg107 also
formed a salt bridge, thereby contributing to the interaction
with the uracil base ring of the substrate. Thus, the loss of
the ribonuclease activity due to mutations of these two resi-
dues demonstrates their importance with regard to the uridine
binding revealed by our structure. Lys59 may also contribute
to the substrate binding with the phosphate group.
Therefore, the residues found in this study and by Lin et al.
are crucial for the catalytic activity; however, none of these
appear to be apparent catalytic residues, suggesting the
existence of an alternative novel mechanism responsible for
the E5 activity.
In deoxyribonucleases (DNases), a water molecule that is
activated by divalent metal ions is involved in the catalytic
reaction. However, no metal ions were found to be associated
with the E5-CRD/dGpdUp complex; in fact, the enzyme
reaction was resistant to EDTA (data not shown). Although
a water molecule was found to bind to O1P of the phosphate
of dGpdUp in the active site, it may function to ﬁx the
substrate at the active site.
E5-CRD/ImmE5 mimics the molecular recognition of
RNA–RNA interaction
Recently, Luna-Cha ´vez et al. have solved the crystal structure
of E5-CRD complexed with its cognate inhibitor protein
ImmE5 through a multiwavelength anomalous diffraction
experiment (21). We have also been studying the same
structure by using MIR. As a result, when we superposed
our E5-CRD/ImmE5 structure onto the structure obtained
by Luna-Cha ´vez et al., the r.m.s. difference for the backbone
atoms (Ca, C, O and N) was 0.18 s. The resolutions of our
structure and their structures are 1.9 and 1.15 s, respectively.
As shown in the case of barnase-barstar (33), this may
indicate that the E5-CRD/ImmE5 complex structure is very
rigid, thereby suggesting the tight binding to the target
tRNAs. However, the free E5-CRD structure is rather ﬂexible
as shown in Figure 2. The interaction of E5-CRD and ImmE5
was realized mainly by the electrostatic interaction between
the positive charges on E5-CRD and the negative charges
on ImmE5. In addition to the observation on this binding
mode by Luna-Cha ´vez et al., we found that 12 water
molecules interacted with the main chains or side chains of
ImmE5 and E5-CRD through the hydrogen bonds resulting
in the ﬁlling of the gap between the two proteins; this may
contribute to their tight binding. As determined in a prelimi-
nary modeling study on E5-CRD and the tRNA molecule, an
anticodon loop ﬁts in the pocket within which are located
a long loop (Phe60–Pro73) comprising two short strands
and a helix of ImmE5 (Figure 6). Based on this conformation
of the interaction of E5-CRD/ImmE5, we considered that the
long loop region in ImmE5 may mimic the anticodon loop
of a tRNA. Additionally, the basic residues Lys25, Arg33
and Lys60, which are essential for the catalytic activity of
E5-CRD are in contact with the acidic residues Asp51
and Asp94 in ImmE5. When we superposed the E5-CRD/
ImmE5 complex structure onto the E5-CRD/dGpdUp
complex structure, the positions of Asp51 and Asp94 corre-
sponded with those of the two phosphates of dGpdUp
(Figure 7). This suggests that the acidic residues in ImmE5
mimic the phosphates in the anticodon; thus, ImmE5 inhibits
the E5-CRD activity by mimicking the binding mode of the
tRNA anticodon loop.
Figure 6. The structure of E5-CRD complexed with ImmE5. E5-CRD and
ImmE5 are represented in magenta and cyan, respectively. The loop region
(Phe60–Pro73) of ImmE5 is represented in blue. In the E5-CRD/dGpdUp
complex structure, only dGpdUp is represented as a ball-and-stick model. The
position of dGpdUp is derived by the superposition of E5-CRDs complexed
with ImmE5 or dGpdUp.
6080 Nucleic Acids Research, 2006, Vol. 34, No. 21As described above, dGpdUp binds to E5-CRD using
ring–ring interactions and hydrogen bonds at base rings in
a manner similar to the Watson–Crick-type interaction
(Figure 3A and C). Thus, it is very likely that the E5-CRD/
dGpdUp binding mode mimics an mRNA–tRNA interaction.
If E5-CRD mimics mRNA while binding to tRNA and
ImmE5 mimics tRNA while binding to E5-CRD, we
speculate that the molecular recognition mode of the
protein–protein interaction in E5-CRD/ImmE5 may be the
culmination of the molecular evolution originating from
the mRNA–tRNA interaction.
In the evolutionary process, initially, E5-CRD could
replace the mRNA interacting with the tRNA by means of
Trp102 and Asp105–Arg107 that mimicked the nucleotide
base stacking with the G–U nucleotides of tRNA. Trp102
and Asp105–Arg107 in E5-CRD mimicked the nucleotide
bases in the mRNA, suggesting the interaction of Trp102
and Asp105–Arg107 with G–U. Subsequently, additional
interactions between the phosphate groups of the substrate
and basic residues in E5-CRD were established to stabilize
the binding (the interactions between blue-colored residues
and dGpdUp in Figure 7). Then, ImmE5 could replace
the tRNA to interact with E5-CRD; the guanine base was
replaced by Phe60 of ImmE5, and two phosphates were
replaced by Asp51 and Asp94. Due to this replacement, the
hydrogen bonds and the ring interactions between dGpdUp
and the residues in E5-CRD are almost precisely retained
by the residues in ImmE5 and E5-CRD at the corresponding
positions.
CONCLUSION
The E5-CRD/dGpdUp complex structure reported here
clearly demonstrated the mechanism by which sequence-
speciﬁc recognition is achieved by colicin E5. The crystal
structures of RNases such as RNase A (34), T1 (35) and
barnase (36) have been solved using their corresponding
substrates. When compared with these, the recognition
mechanism of E5-CRD was unique and corresponded to the
substrate speciﬁcity. We also found three basic residues
that are important for the E5-CRD activity. However, since
the pKa values of their side chains are very high and no
other charged residues are present around the cleavage site,
the precise catalytic mechanism without histidines remains
to be elucidated.
In addition to the analysis of the E5-CRD functions, a com-
parison of the crystal structures of the E5-CRD/ImmE5 and
E5-CRD/dGpdUp complexes suggested that both E5-CRD
and ImmE5 mimic the molecular recognition mechanism of
RNA, in which a pair comprising a ribonuclease and the
cognate inhibitor protein replaced the RNA–RNA interaction
to realize the protein–protein interaction through an RNA–
protein interaction. In the evolutionary process of molecules,
if RNAs were to be the sole precursors, the roles of RNA
molecules could have been fulﬁlled by proteins following
their emergence. Thus, the E5-CRD/ImmE5 complex struc-
ture might represent an example of this evolutionary process.
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